RAF plus EGFR Inhibition for BRAF-Mutant Metastatic Colorectal Cancer-Response

Clin Cancer Res. 2015 May 1;21(9):2188. doi: 10.1158/1078-0432.CCR-15-0412.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Colorectal Neoplasms / drug therapy*
  • ErbB Receptors / antagonists & inhibitors*
  • Female
  • Humans
  • Indoles / therapeutic use*
  • Male
  • Proto-Oncogene Proteins B-raf / antagonists & inhibitors*
  • Sulfonamides / therapeutic use*

Substances

  • Antibodies, Monoclonal
  • Indoles
  • Sulfonamides
  • ErbB Receptors
  • Proto-Oncogene Proteins B-raf